Investors / United States / Biomatics Capital
Biomatics Capital
Venture capital · Seattle, WA, United States · North America
Biomatics Capital is an investment firm focused on health care and medicine, backing companies that apply genomics and digital data to therapeutics, diagnostics, and delivery models. The firm states it is fully committed and no longer investing in new opportunities.
Invests inHealthcare & Biotech
In its own wordsgenomicsdigital healththerapeuticsdiagnosticshealthcarebiotech
Your fit with Biomatics Capital
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsBiomatics Capital lists 12 checked portfolio companies on its own site. Its largest themes are Healthcare & Biotech (85%), Media & Entertainment (8%) and Education (8%). 100% of its companies are based in United States. It invests most often alongside ARCH Venture Partners, Casdin Capital and Catalio Capital Management.
No funding round on record names Biomatics Capital yet, so the figures come from its portfolio page.
Round figures show recent activity, not Biomatics Capital's whole history. Rounds on record name 0 companies; its own site lists 12. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 30th | 12 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 94th | 85% in its largest sector |
| Reach | 19th | 1 country |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers12100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 85% | 15% |
| Media & Entertainment | 8% | 4% |
| Education | 8% | 7% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with ARCH Venture Partners
Compare Biomatics Capital head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Portfolio
12 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| AiCure develops and provides AI-powered clinical trials software and medication adherence verification platforms | Healthcare & Biotech | Portfolio page | ||
| Aledade provides actionable insights and expert support for clinicians to keep their patients healthy while generating sustainable revenue through its accountable care organizations (ACOs). | Healthcare & Biotech | Portfolio page | ||
| Cytrellis is a medical technology company dedicated to the development and commercialization of first-in-class aesthetic devices. | Healthcare & Biotech | Portfolio page | ||
| Denali Therapeutics discovers, develops and delivers medicines for people living with serious diseases. | Healthcare & Biotech | Portfolio page | ||
| Editas Medicine develops transformative and durable medicines for people living with serious diseases using CRISPR gene editing technology | Healthcare & Biotech | Portfolio page | ||
| eGenesis develops human-compatible organs for patients with organ failure using genome engineering and transplantation | Healthcare & Biotech | Portfolio page | ||
| GRAIL develops and offers a multi-cancer early detection test that can screen for various types of cancer using a blood test. | Healthcare & Biotech | Portfolio page | ||
| Neumora develops medicines for brain diseases | Healthcare & Biotech | Portfolio page | ||
| Thrive offers behavior change solutions to support users in building healthier habits | Healthcare & Biotech | Portfolio page | ||
| The company synthesizes DNA and provides related products and services for research and development. | Healthcare & Biotech | Portfolio page | ||
| Verana Health provides real-world evidence solutions for clinical research and patient care | Healthcare & Biotech | Portfolio page | ||
| Verve provides a global omnichannel advertising platform for brands and publishers | Media & EntertainmentEducation | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- biomaticscapital.com
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Companies checked
- 12
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Biomatics Capital's profile as data
Pull Biomatics Capital's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/biomaticscapital.com
# also
GET /v1/firms/biomaticscapital.com/portfolio
GET /v1/firms/biomaticscapital.com/coinvestors
GET /v1/firms/biomaticscapital.com/news